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INTRODUCTION
Multiple sclerosis (MS) is a chronic autoimmune and neuro-
degenerative central nervous system disorder that is charac-
terised by inflammation, demyelination and primary or sec-
ondary axonal degeneration (Trapp et al., 1998). MS is the
most common reason of non-traumatic disability in young
adults and there are more than 2.3 million MS patients in
the world (Browne et al., 2014).
The pathogenesis of MS is not entirely clear. For a long
time it was considered to be a primarily demyelinating dis-
ease, but there is increasing evidence that neurodegenera-
tion and axonal damage begins early and plays a more im-
portant role (Bruck, 2005; Zipp and Aktas, 2006; Fisniku et
al., 2008; Siffrin et al., 2010).
There are no identified factors that cause expressed MS
variability and transformation to the progressive and treat-
ment-resistant stage. MS cannot be completely cured and
available treatment is mainly based on inflammation de-
crease, which barely impacts neurodegeneration (Costello,
2013). There is increased need for neuroprotective treat-
ment and biological markers to follow the course of the dis-
ease and treatment effectiveness (Fernandez, 2013).
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There is insufficient information about the progress and variability of multiple sclerosis (MS). Af-
ferent visual pathways are an appropriate MS clinical model. Optical coherence tomography
(OCT) allows to perform precise measurements of axonal tissue in the retinal nerve fibre layer
(RNFL). Visual evoked potentials (VEP) provide information about the functional status of visual
pathways. The aim of our study was to use OCT and VEP to evaluate MS patients with and with-
out optic neuritis (ON) history and to determine relationships between functional and structural
changes. The cross-sectional study included 76 relapsing-remitting MS patients and 28 healthy
controls. The lowest mean VEP N75/P100 amplitude was found in ON affected eyes (8.16 mkV,
SD = 4.60). However, it was observed that the mean amplitude in patients without ON (M = 9.86;
SD = 4.63) was by 4.64 mkV lower than in controls (p < 0.001). Similarly, the mean P 100 latency
in ON eyes was 9.26 ms longer than in eyes of patients without ON history (p < 0.01). RNFL in
the temporal segment (RNFLT) was the thinnest in ON eyes, and even in patient eyes without
ON, it was thinner than in controls. We found a significant positive correlation between RNFLT
and mean N75/P100 amplitude in patients without ON (rs = 0.43; p < 0.001), and after ON (rs =
0.45; p < 0.001). Both in patients without ON (rs = –0.40; p < 0.001) and in ON eyes we found a
significant negative correlation (rs = –0.55; p > 0.001) between RNFLT and mean P100 latency. In
summary, we found that deterioration in the visual system was not associated with the clinical ON
episode. Regardless of ON symptoms in history, there exists correlation between functional and
structural changes.
Key words: multiple sclerosis, optic nerve, axonal damage, visual evoked potentials, optical co-
herence tomography.
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Afferent visual pathways are an appropriate MS clinical
model. MS often affects visual pathways, as almost 70% of
MS patients will experience an optic neuritis (ON) episode
in their lifetime (Di Maggio et al. 2014). Afferent visual
pathways represent an acute demyelination episode through
acute ON, while in the case of chronic, subclinical retinopa-
thy and optic neuropathy — diffuse, chronic central nervous
system damage. For better understanding of MS, recently a
new biological marker was proposed — optical coherence
tomography (OCT), which allows to perform precise meas-
urements of retinal axonal tissue in the retinal nerve fiber
layer (RNFL). Visually evoked potentials (VEP) provide in-
formation about functional status of visual pathways.
The aim of our study was to use VEP and OCT to evaluate
MS patients with and without ON history and to determine
relationships between functional and structural changes.
MATERIALS AND METHODS
The cross-sectional study included 76 relapsing-remitting
MS patients who were divided into two groups:
- MS patients without ON symptoms in history;
- MS patients with ON history.
In the MS patient group with ON history, ON-affected eyes
(ON+) and contralateral, ON-unaffected eyes (ON–) were
analysed separately
The control group included 28 age-matched and sex-
matched healthy individuals.
MS patients were selected from the Pauls Stradiòð Clinical
University Hospital Multiple Sclerosis Centre during the
period from October 2011 to April 2014. The study was ap-
proved by the local research ethics committee. Part of the
MS patients continued their immunomodulatory therapy.
Inclusion criteria were:
- relapsing remitting MS diagnosis, based on the 2010 Mc-
Donald criteria;
- for MS patients with a history of ON > 6 months after
unilateral ON episode;
-  30 days after corticosteroid therapy.
Exclusion criteria:
- acute ON clinical signs;
- refraction disorders exceeding ± 6 diopters;
- other neurological and ophthalmic diseases, which could
affect the afferent visual system;
- inability to participate in visual system examinations.
A history of ON was determined on the basis of symptoms
and clinical signs (Voss et al., 2011). Neurological exami-
nation of patients with disability was assessed using the
Kurzke Expanded Disability Status Scale (EDSS). In clini-
cal assessment of the ophthalmological condition, the
following functional and structural visual system tests were
made separately for each eye.
Visual acuity was tested with the Snellen chart. For all par-
ticipants, the pattern–reversal VEP record was performed
using hardware “RETI port 21 ROLAND CONSULT”. In-
dividuals were placed 70 cm away from the screen, fixing
their view on the red dot in the centre of the screen. When
required, a full refractive correction was made. For estab-
lishing of potential, vision was repeatedly stimulated in a
monocular way with a black-white video monitor at 1.6 Hz
frequency. Record of the potential was made with disc elec-
trodes, placing them in the brain visual cortical projection
areas of the International 10–20 system; the active and ref-
erence electrodes were placed according to Oz and Fz areas
(Odom et al. 2010). The average potentials of action were
filtered and analysed, repeatedly performing 100 re-stimul-
ations twice for each eye. N75/P100 amplitude measure-
ments in microvolts (mkV), as well as P 100 latency mea-
surements in milliseconds (ms) were made. Based on
recommendations of the International Federation of Clinical
Neurophysiology on the limits for evaluation of measure-
ments made using the VEP hardware, N75/P100 amplitude
below 10.52 mkV was considered to be reduced, and P100
latency longer than 110.25 ms was considered to be ex-
tended.
Using the OCT method (Heidelberg Engineering SPEC-
TRALIS), RNFL thickness was measured in six standard
sectors (temporal, temporal upper, temporal lower, nasal,
nasal upper and nasal lower) with measurements expressed
in micrometers (mkm). For all study participants, active Tru
Track eye tracking technology was used. RNFL thickness
results were evaluated using the OCT normative database,
where green marked areas were classified as normal, and
the red marked areas were considered abnormally reduced.
OCT images of unsatisfactory quality were rejected.
For statistical analysis, the IBM SPSS v.22. software was
used. Data were presented as mean (M) and standard devia-
tion (SD) or median (Me) and interquartile range (IQR) for
continuous variables, and counts for categorical variables.
Logistic regression modelling techniques were used to de-
termine patient factors that were associated with the binary
outcome. Significant differences of quantitative variables
between groups were tested using the Student’s t test. Cor-
relation between variables was assessed using the
Spearman’s correlation test. All tests were two-sided and
statistical significance was considered at p < 0.05.
RESULTS
The study included 76 MS patients with minimum age 17
years and maximum age 65 years. The control group in-
cluded 28 healthy subjects aged 19 to 65 years. It was found
that age of MS patients and the control group did not sig-
nificantly differ (t-test; p > 0.05). The mean disease dura-
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tion in MS patients was 39.56 months (6 to 384 months). In
both MS patient groups, the modal EDSS step was 1.5 and
the maximum was 6. The medians of EDSS in the MS pa-
tient groups did not significantly differ (Mann-Whitney test;
p > 0.05). The mean corrected visual acuity in MS patients
was 0.94 (SD = 0.25), and lowest value of the corrected vis-
ual acuity was 0.02. Demographic and clinical details of MS
patients and controls are reproduced in Table 1.
The N75/P100 VEP amplitude was lower in the MS patient
group with ON history, particularly in the ON+ eyes (8.16
mkV (SD = 4.60)). The mean amplitude was 2.87 mkV
lower than in ON– eyes (p = 0.01). Furthermore, a lower
N75/P100 amplitude was observed in MS patients without
any ON history, compared to that in the control group. The
independent samples t test showed that that the mean ampli-
tude in MS patients without ON (M = 9.86; SD = 4.63) was
significantly lower (by 4.64 mkV, p < 0.001), than in the
control group (M = 14.51; SD = 3.35). Similarly, mean
P 100 latency in ON+ eyes was 9.26 ms longer than in eyes
of MS patients without any ON history (p < 0.01). Also, the
mean P 100 latency was 11.25 ms longer in ON+ eyes com-
pared with that in ON– eyes (p < 0.01) in the MS patient
group with ON clinical signs in their history.
Comparing the control group and MS patients using OCT
measurements, the RNFL set significantly different in all
quadrants (p < 0.05). ROC curve analysis showed that the
biggest RNFL difference was in the temporal quadrant
(RNFLT) (accordingly AUC = 0.72; 95% CI: 0.64 to 0.79;
p < 0.01). RNFLT was thinner in ON+ eyes, but even in MS
patient eyes without ON symptoms history, this layer was
8.45 µm thinner than in the control group. The mean
RNFLT differed between the three study groups (p <
0.001). Furthermore, age of individuals did not have a sig-
nificant effect on these differences (ANCOVA; p > 0.05).
Mean VEP amplitudes, latencies and RNFLT measurements
are shown in Table 2.
Spearman’s correlation coefficient analysis showed a posi-
tive correlation (rs = 0.43; p < 0.001) in MS patients without
ON history between RNFLT and mean N75/P100 ampli-
tude, and in ON+ eyes (rs = 0.45; p < 0.001). There was
negative correlation (rs = –0.55; p < 0.001) between RNFLT
and P100 latency in patients without an ON history (rs=
–0.40; p < 0.001) and ON + eyes (Figs. 1 and 2).
DISCUSSION
In our study the thinnest RNFL was observed in ON+ eyes,
but also in eyes without previous ON this layer was signifi-
cantly thinner than in the control group. This finding con-
firms the observed subclinical ongoing axonal tissue dam-
age in numerous previous studies (Parisi et al., 1999; Pueyo
et al., 2008; Zaveri et al., 2008; Garcia-Martin et al., 2010,
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MS, multiple sclerosis; ON, optic neuritis; EDSS, Expanded Disability Sta-
tus Scale; IQR, interquartile range; SD, standard deviation
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eyes (n = 86)
Controls,
eyes (n = 56)
ON+ (n = 33) ON- (n = 33)
Mean N75/P100 amplitude, mkV, (SD) 8.16 (4.6) 11.03 (5.40) 9.86 (4.63) 14.15 (3.35)
Mean P100 latency, ms, (SD) 126.0 (18.26) 114.75 (11.94) 116.73 (16.00) 101.81 (5.66)
Mean RNFLT, mkm (SD) 56.44 (16.51) 62.12 (13.92) 62.47 (11.18) 70.92 (7.12)
For abbreviations see Table 1. RNFLT, retinal nerve fiber layer in the temporal segment
Fig. 1. Relationship of RNFLT (retinal nerve fiber layer in the temporal
segment) with mean N75/P100 amplitude. MS, multiple sclerosis; ON, op-
tic neuritis
Quelly et al., 2010; Fjeldstad et al., 2011). In a large meta-
analysis it was estimated that RNFL is about 20 µm thinner
in ON+ eyes than in controls (Petzold et al., 2010). Accord-
ing to our results, the mean difference was not as pro-
nounced (14 µm), which might indicate transaxonal degen-
eration after an acute demyelinating event.
Less understandable is the decrease of the axonal tissue
layer thickness in patients without any ON clinical signs in
their history. These changes may suggest chronical axonal
tissue involvement during progress of the disease. Further-
more, this may be considered as a biological marker that
can be monitored in different clinical situations. Subclinical
decline in parameters of VEP also may indicate dynami-
cally deteriorating functional status of the nervous system.
The literature on usefulness of VEP and OCT in subclinical
ON diagnostics are controversial. There are studies that find
both of these methods to be helpful for subclinical involve-
ment detection (Trip et al., 2005; Fisher et al., 2006; Klis-
torner et al., 2008; Naismith et al., 2009; Talman et al.,
2010). Our study showed significant correlation between
RNFLT with mean VEP amplitude and latency, as previ-
ously observed (Naismith et al., 2009; Di Maggio et al.,
2014). However, a few authors have described a relation-
ship between RNFLT and P 100 latency, (Fatehi et al.,
2012), and with N75/P 100 latency (Trip et al., 2005). Tak-
ing into account that these methods assess different damage
aspects (structural and functional), it may be advised to per-
form both of them for patients without specific complaints
about vision. Furthermore, RNFLT charcterises only the an-
terior part of visual pathways, while VEP shows integrity of
the whole visual system from retina to visual cortex. To im-
prove the sensitivity of OCT, recently it was suggested to
perform inner plexiform layer and ganglionic layer meas-
urements (Davies et al., 2011; Seigo et al., 2012; Walter et
al., 2012), which could more precisely quantify axonal tis-
sue, as these structures do not contain glia cells and blood
vessels (Hood et al., 2010).
In conclusion, there are functional and structural changes in
afferent visual system that are not associated with the clini-
cal optic nerve inflammation episode. Regardless of ON
clinical presence, there exists a correlation between func-
tional and structural changes in the afferent visual system.
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FUNKCIONÂLAS UN STRUKTURÂLAS REDZES SISTÇMAS IZMAIÒAS MULTIPLÂS SKLEROZES PACIENTIEM
Multiplâs sklerozes (MS) gaita ir mainîga un grûti prognozçjama. Redzes sistçma var tikt analizçta kâ MS klîniskais modelis. Ar optiskâs
koherences tomogrâfijas (OCT) metodi iespçjams veikt precîzus aksonâlo audu mçrîjumus, mçrot tîklenes nervu ðíiedru slâni (RNFL).
Izmantojot redzes izsaukto potenciâlu metodi (VEP), iespçjams analizçt redzes sistçmas funkcionâlo stâvokli. Pçtîjuma mçríis bija veikt
redzes sistçmas izmeklçjumus ar OCT un VEP metodçm MS pacientiem ar un bez redzes nerva neirîta (ON) epizodes anamnçzç, kâ arî
noskaidrot strukturâlo un funkcionâlo izmaiòu savstarpçjâs saistîbas. Ðíçrsgriezuma pçtîjumâ tika iekïauti 76 recidivçjoði remitçjoðas MS
pacienti, kâ arî 28 kontroles grupas indivîdi. Zemâkâ vidçjâ VEP N75/P100 amplitûda tika konstatçta acîs pçc ON epizodes (8,16 mkV,
SD = 4,60), taèu arî pacientiem bez ON anamnçzç vidçjâ VEP amplitûda bija par 4,64 mkV zemâka, salîdzinot ar kontroles grupu
(p < 0.001). Lîdzîgi vidçjâ VEP P100 latence ON skartajâs acîs bija par 9,26 ms garâka, salîdzinot ar pacientiem, kuriem ON klînisko
pazîmju anamnçzç nav bijis (p < 0,01). Analizçjot RNFL temporâlajâ segmentâ (RNFLT), visplânâkais tas bija acîs pçc ON epizodes, tomçr
arî MS pacientiem bez ON pazîmçm tas bija plânâks nekâ kontroles grupai. Tika konstatçta pozitîva korelâcija starp RNFLT un vidçjo
N75/P100 amplitûdu gan pacientiem pçc ON epizodes (rs = 0,43; p < 0,001), gan pacientiem bez ON klîniskajâm pazîmçm anamnçzç
(rs =0,45; p < 0,001). Arî vidçjai P100 latencei tika konstatçta saistîba ar RNFLT gan pacientu grupâ pçc ON (rs = -0,55; p < 0.001), gan arî
pacientiem bez iepriekð pârciesta ON (rs = -0,40; p < 0,001). MS pacientiem vçrojamas subklîniskas funkcionâlas un strukturâlas izmaiòas
redzes sistçmâ, kas nav saistîtas ar klînisku ON epizodi. Neatkarîgi no ON klîniskajâm pazîmçm anamnçzç vçrojamas korelâcija starp
strukturâlâm un funkcionâlâm izmaiòâm redzes sistçmâ.
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